Published 7 days ago • loading... • Updated 7 days ago

NEARLY 40% OF ECZEMA PATIENTS FACE INSURANCE BARRIERS, ACCORDING TO NEW DATA PRESENTED ON CAPITOL HILL BY THE NATIONAL ECZEMA ASSOCIATION (NEA)

On February 24, 2026, the National Eczema Association presented newly available interim data at a U.S. Congressional briefing on Capitol Hill showing nearly 40% of eczema patients and caregivers reported insurance coverage issues, and 15% never started prescribed medication due to insurance barriers.
NEA says administrative burdens from insurance policies are delaying eczema treatments, urging lawmakers to reduce prior authorization hurdles and increase federal research funding.
The NEA breakdown reveals therapy denials and retries, with more than 35% facing step therapy and 56% encountering prior authorization, according to NEA's 2025 Access to Prescription Treatment Survey.
The hour-long briefing featured NEA leaders Kristin Belleson, Wendy Smith Begolka, and Jiwon Park, with Congressional staff from both the U.S. House and Senate attending and sharing patient experiences.
With more than 31 million Americans living with eczema, NEA warned that 'The science has moved forward, but coverage policy has not kept pace' and urged continued federal research support.

Insights by Ground AI

11 Articles

Helena Independent Record

+10 Reposted by 10 other sources

Center

NEARLY 40% OF ECZEMA PATIENTS FACE INSURANCE BARRIERS, ACCORDING TO NEW DATA PRESENTED ON CAPITOL HILL BY THE NATIONAL ECZEMA ASSOCIATION (NEA)

NOVATO, Calif., March 4, 2026 /PRNewswire/ -- Nearly 40% of eczema patients and caregivers surveyed by the National Eczema Association (NEA) reported at least one insurance coverage issue in the past year, and 15% never started a prescribed medication due…

7 days ago·Helena, United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year